Results out today confirm that the drug donanemab, hailed as a turning point in the fight against Alzheimer’s, slows cognitive decline by about a third.
The antibody treatment helps in the early stages of the disease.
It works in Alzheimer’s disease, not in other types of dementia, such as vascular dementia.
That is because it is designed to clear away one of the key features of Alzheimer’s disease – a substance called amyloid that builds up in the spaces between brain cells.
Please subscribe here: http://bit.ly/1rbfUog
#Dementia #Alzheimers #BBCNews
VANCOUVER (CANADA) (ITALPRESS) – La Svizzera vola ai quarti di finale del Mondiale battendo la Colombia per 4-3 ai calci…
L'edizione della notte del Tg diretto da Enrico Mentana
The US has launched a series of "powerful" strikes on Iran in response to attacks on three commercial vessels in…
WARNING: This video discusses violence and sexual assault. A new investigation by the BBC has uncovered details about secret prisons…
PECHINO (CINA) (XINHUA/ITALPRESS) – La Cina ha aperto 92 nuove rotte aeree internazionali per il trasporto merci nel primo semestre…